$0.6840
-0.03-3.66%
At close: -
$0.6999
0.022.32%
After Hours: Dec 20, 7:55 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Unicycive Therapeutics in recent months.
Browse guidance and forecast on all stocks.